NSAID Kidney-Safety Checklist
This page intentionally does not assign points, a probability, or a low/high band. No validated bedside point score supports those outputs for NSAID-related kidney injury.

In short: An educational NSAID renal risk checklist: 11 risk factors for NSAID-related acute kidney injury, the triple whammy explained, and plain-language actions for each band. No validated score exists; this is a transparent checklist, not a prediction. Use the calculator above, then read the guide below to interpret your result and its limitations.
The NSAID renal risk checklist
How NSAIDs can injure the kidneys
Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, diclofenac, naproxen, and celecoxib work by blocking cyclo-oxygenase enzymes (COX-1 and COX-2). This reduces prostaglandin production, which is how they relieve pain and inflammation. The problem is that prostaglandins also do important work in the kidneys.
In the kidney, prostaglandins such as prostaglandin E2 and prostacyclin dilate the afferent arteriole, the small vessel that carries blood into each glomerulus. This dilation keeps glomerular blood flow and filtration steady. When the body's effective circulating volume falls, for example in heart failure, cirrhosis, or dehydration, the kidneys become heavily dependent on prostaglandins to keep that blood flow up. If an NSAID then removes the prostaglandins, the afferent arteriole constricts, blood flow into the glomerulus drops, and the glomerular filtration rate (GFR) can fall sharply.
The most common result is a haemodynamic form of acute kidney injury: a sudden reduction in filtration without permanent structural damage. In most cases it is reversible if the NSAID is stopped promptly, and urine output often falls within a day or two of starting the drug in susceptible people. Less commonly, NSAIDs trigger acute interstitial nephritis, an immune-mediated inflammation of the kidney tissue, which is a different mechanism and can present later with fever, rash, or urinary changes. Because the haemodynamic mechanism depends on blood flow and pressure, it strikes hardest when several risk factors stack together, which is exactly what the checklist above is designed to surface.
The risk factors, one by one
Each factor on the checklist is backed by published guidance on NSAID-related kidney injury. Here is why each one matters.
Patient factors
Age 65 or older. With ageing, the renal arterioles narrow and the kidneys lose some of their ability to dilate the afferent vessel on demand. Medicine safety guidance from New Zealand's Medsafe lists increasing age, particularly over 65, as a core risk factor for NSAID-induced acute kidney injury.
Chronic kidney disease. Kidneys that are already damaged rely on compensatory dilation of the afferent arteriole to keep the GFR up. Medsafe names pre-existing glomerular disease or renal insufficiency as a situation in which that dilation is likely to be required, which is precisely the mechanism NSAIDs disable.
Heart failure and cirrhosis. These cause what physiologists call effective volume depletion: the body holds fluid, but too little of it is effectively circulating to the kidneys. The kidneys respond by secreting angiotensin II and leaning on prostaglandins. Both conditions appear in the Medsafe risk-factor table and in nephrology teaching summaries of classic high-risk patients.
Diabetes. Diabetes appears in nephrology teaching lists of the classic high-risk patient for drug-induced acute kidney injury, alongside kidney disease, the elderly, and volume-depleted patients. It often travels with other factors on this list, such as CKD and ACE inhibitor use.
Low blood pressure. Because NSAID injury is haemodynamic, it is pressure dependent. Episodes of hypotension reduce the perfusion pressure that drives filtration, leaving no margin when prostaglandin support is withdrawn.
Medication factors
Diuretics. Diuretics reduce plasma volume, which is one leg of the triple whammy described below. They are also a recognised cause of true volume depletion in their own right.
ACE inhibitors and ARBs. These drugs block the renin-angiotensin system, preventing the compensatory constriction of the efferent arteriole that maintains glomerular pressure. Medsafe notes that ACE inhibitors and ARBs prevent efferent arteriole vasoconstriction that is important in maintaining GFR, which is why they pair badly with NSAIDs.
Other kidney-damaging drugs. Aminoglycoside antibiotics, lithium, calcineurin inhibitors such as ciclosporin and tacrolimus, and iodinated contrast agents can injure the kidneys through direct tubular effects or other mechanisms. Pharmacist guidance warns that adding other medicines known to cause kidney problems compounds the issue when combined with an NSAID.
High dose or long duration. Chronic or high-dose NSAID use gives injury more opportunity to develop, and pharmacist guidance notes that NSAIDs can tip the balance in patients who already carry several risk factors. Where an NSAID is needed, the standing advice is the lowest effective dose for the shortest duration.
The triple whammy
The "triple whammy" is the concurrent use of three medicine classes: an ACE inhibitor or ARB, a diuretic, and an NSAID (including COX-2 selective inhibitors and over-the-counter NSAIDs). Each of the three can reduce renal function on its own, and prescribers' guidance from New Zealand's Best Practice Advocacy Centre states plainly that when all three are prescribed together, the risk of acute kidney injury is greatest.
The physiology is a three-way squeeze on the glomerulus. The NSAID blocks prostaglandin-mediated dilation of the afferent arteriole, causing it to constrict and reducing blood flow into the glomerulus. The ACE inhibitor or ARB blocks angiotensin II, dilating the efferent arteriole and dropping the pressure that drives filtration. The diuretic reduces plasma volume, lowering renal blood flow further. A pharmacovigilance analysis of emergency department visits and hospitalisations in Italy confirmed that this combination is associated with acute kidney injury events severe enough to require hospital care.
The practical guidance is clear. Wherever possible, NSAIDs should not be prescribed to patients already taking an ACE inhibitor or ARB with a diuretic, and those patients should be warned to avoid over-the-counter NSAIDs too. If the combination is genuinely unavoidable, baseline serum creatinine and electrolytes should be measured, the patient should be told to maintain adequate fluid intake, and kidney function should be rechecked early. The checklist flags the triple whammy explicitly because it is the single most actionable pattern it can detect.
Why this is a checklist, not a score
What that means for you: a "Lower risk" result is not a green light. It means none of the classic factors applied, but kidney injury can still occur, especially with dehydration, high doses, or long courses. A "Higher risk" result does not mean injury is likely or inevitable; it means several known risk amplifiers are present and a clinician should be involved before NSAID use becomes regular. Treat the bands as a prompt for the right conversation, not as a verdict.
Monitoring when an NSAID is used
When a higher-risk person genuinely needs an NSAID, pharmacist guidance recommends checking kidney function (serum creatinine and eGFR) and electrolytes within about two weeks of starting, and then periodically while use continues. A clinician may check sooner if there are extra risk factors, if the patient becomes unwell, or if symptoms appear.
Hydration deserves special attention. Patients should be counselled to keep up fluid intake while taking NSAIDs, and to be especially careful during acute illness, hot weather, vomiting, or diarrhoea, because dehydration is one of the fastest ways for risk to jump. During such episodes, it is reasonable to pause the NSAID and seek advice, particularly for people in the Moderate or Higher bands. Patients should also be told the warning signs that need immediate care: swelling, a marked drop in urine output, and confusion.
Medication review is the third pillar. Every new prescription, over-the-counter purchase, or dose change is a chance to re-run the checklist mentally. New diuretics, new blood pressure medicines, new courses of antibiotics, and contrast imaging procedures can all move a person into a higher band without anyone noticing unless someone asks.
Safer alternatives to oral NSAIDs
For many types of pain, paracetamol (acetaminophen) is the recommended first choice, because it does not carry the kidney, cardiovascular, or gastrointestinal risks of NSAIDs. It is not suitable for every situation, and it has its own dosing limits, but it should be considered before an oral NSAID in anyone with risk factors.
For localised joint pain, particularly mild osteoarthritis pain in smaller joints such as the hand or knee, a topical NSAID is a useful middle path. Pharmacist guidance notes that systemic absorption from topical preparations is low, so the kidney exposure is far smaller than with tablets. Heat, cold, rest, physiotherapy, and weight management where relevant are non-drug options that carry no kidney risk at all.
When an oral NSAID is genuinely needed, the universal advice applies: the lowest effective dose for the shortest possible duration. It is also worth knowing two things that are commonly misunderstood. No oral NSAID has been shown to be safest for the kidneys, so switching brands is not a protective strategy. And the idea that short-acting NSAIDs such as ibuprofen are the least kidney-toxic is not supported by evidence. Choice of NSAID should be based on the whole risk picture, including cardiovascular and gastrointestinal risks, in discussion with a clinician.
When to seek urgent care
Acute kidney injury can develop quickly. Seek immediate medical attention for swelling, especially of the legs, ankles, or around the eyes; a marked reduction in urine output; or new confusion. Do not wait to see whether these settle on their own, and mention NSAID use explicitly to the clinician, including any over-the-counter tablets. If you feel acutely unwell with vomiting, inability to keep fluids down, or faintness while taking an NSAID, stopping the drug and seeking advice the same day is the safer course.
Key takeaways
- No.
- The triple whammy is the concurrent use of an NSAID with an ACE inhibitor or ARB plus a diuretic.
- Older adults (particularly over 65), people with chronic kidney disease, heart failure, cirrhosis, diabetes, dehydration, or low blood pressure, and people taking diuretics, ACE inhibitors or ARBs, or other kidney-damaging drugs are most at risk.
- In higher-risk patients who need an NSAID, kidney function and electrolytes are commonly checked within about two weeks of starting and then periodically.
Frequently asked questions
Is there a validated NSAID kidney risk score?
What is the triple whammy?
The triple whammy is the concurrent use of an NSAID with an ACE inhibitor or ARB plus a diuretic. The NSAID constricts the kidney's afferent arteriole, the ACE inhibitor or ARB dilates the efferent arteriole, and the diuretic reduces plasma volume. Each of these reduces renal function on its own, and the combination carries the greatest risk of acute kidney injury. People on an ACE inhibitor or ARB with a diuretic should avoid NSAIDs where possible, including over-the-counter ones.
Which people are most at risk of kidney injury from NSAIDs?
Older adults (particularly over 65), people with chronic kidney disease, heart failure, cirrhosis, diabetes, dehydration, or low blood pressure, and people taking diuretics, ACE inhibitors or ARBs, or other kidney-damaging drugs are most at risk. High doses and long durations of NSAID use add to the risk.
How soon should kidney function be checked after starting an NSAID?
In higher-risk patients who need an NSAID, kidney function and electrolytes are commonly checked within about two weeks of starting and then periodically. A clinician may check sooner if there are extra risk factors, dehydration, or symptoms.
What warning signs of acute kidney injury need urgent care?
Swelling (especially of the legs, ankles, or around the eyes), a marked drop in urine output, and confusion are warning signs that need immediate medical attention. Do not wait to see whether they settle on their own.
What can I use instead of an oral NSAID?
Paracetamol (acetaminophen) is the usual first choice for many types of pain. For mild osteoarthritis pain in smaller joints such as the hand or knee, a topical NSAID gives pain relief with low systemic absorption. Always use the lowest effective dose for the shortest time if an oral NSAID is needed, and discuss the plan with a clinician or pharmacist when risk factors are present.
Sources
- Medsafe, New Zealand Medicines and Medical Devices Safety Authority. NSAIDs and Acute Kidney Injury: risk-factor table for NSAID-induced acute kidney injury (age over 65, pre-existing renal insufficiency, volume depletion, ACE inhibitor or ARB use, the triple whammy).
- Best Practice Advocacy Centre New Zealand. Drug combinations and impaired renal function: the "triple whammy": guidance on avoiding the concurrent ACE inhibitor or ARB plus diuretic plus NSAID combination.
- Hospitalisations Related to the Combination of ACE Inhibitors and/or Angiotensin Receptor Blockers with Diuretics and NSAIDs: A Post Hoc Analysis, Journal of Clinical Medicine: mechanisms and hospital-level evidence for triple-whammy-associated acute kidney injury.
- Urine Nephrology student resources. Drug-Induced AKI: Mechanisms and Clinical Management: prostaglandin-dependent renal perfusion, haemodynamic mechanism, and classic high-risk patient factors including diabetes.